SHORT COMMUNICATION
We report an exceptional case of multiple cutaneous and visceral neonatal pyogenic granuloma (PG) initially suggestive of a diffuse neonatal haemangiomatosis.
CASE REPORT
A full-term female newborn, with no significant past medical history, was referred to our department for treatment of an acute respiratory distress syndrome of neurological origin at day 8 of life. At birth, she presented with 3 small angiomatous papules and 4 subcutaneous nodules suggestive of neonatal haemangiomatosis (NH) ( Fig. 1) . A brain MRI revealed a highly vascularised brain stem tumour suggestive of glioma ( Fig. 2) , associated with 2 abnormal hepatic lesions consistent with infantile haemangiomas (IH) on ultrasound and CT scan. Methylprednisolone was started for the suspected glioma-associated oedema, and vincristine and propranolol were introduced for NH. After initial improvement, an acute intracranial hypertension related to cystic evolution of the disease necessitated surgical resection at the age of 2 months. Pathological examinations of the brain, cutaneous and subcutaneous lesions were similar, showing a vascular lobular proliferation of capillaries highly suggestive of PG. The misdiagnosis of glioma was eliminated. The GLUT-1 antigen marker was negative, ruling out the diagnosis of NH-like infantile haemangioma ( Fig.  3 ). Lymphatic marker (D2-40) was also negative and eliminated a multifocal lymphangioendotheliomatosis with thrombocytopaenia (MLT). Cutaneous and hepatic lesions gradually regressed. She is currently in complete remission after completing a treatment over 18 months with propranolol but a spontaneous improvement can not be excluded.
DISCUSSION
Pyogenic granuloma, also known as botryomycoma or lobular capillary haemangioma, is a very common solitary benign vascular tumour, which usually develops on normal skin at the site of minimal skin trauma. At times it occurs spontaneously, particularly in children and
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Departments of 1 Dermatology, 2 Pediatric Oncology, 3 Neonatalogy, 4 Neurosurgergy, 5 pregnant women. Less than 20 cases of disseminated PG or PG-like lesions have been reported in patients suffering from extensive burns, immunosuppression or malignant diseases for individuals treated with the haematopoietic growth factor, probably through angiogenic stimulation. Occasional resolution occurred without treatment (1) .
A congenital occurrence of disseminated cutaneous PG-like lesions has been previously reported in only 5 cases (1-4) (Table I) . Our case is the first to document cerebral lesion in addition to cutaneous ones, which also displayed pathological features of PG with GLUT-1 negativity. This entity can be differentiated from NH-like IH through GLUT-1 immunostaining, among other things. This also illustrates that not all multifocal vascular lesions in infancy are IH and that the liver is not the only other organ to potentially scrutinise (5) .
Indeed, cases similar to our own, along with MLT, Blue Rubber Bleb and others are not so uncommon that we should overlook them, since delaying the diagnosis can lead to considerable morbidity.
These cases of congenital multiple vascular lesions are not only different from NH-like IH, which is not congenital and is GLUT-1 positive, but also are different from common, reactive and solitary PG which develop as an insignificant event in children, although they apparently share similar pathological features. To differentiate this new entity from NH-like IH and common PG, we propose the term PCD angiomatosis for "PG-like Congenital and Disseminated angiomatosis" which accounts for the following criteria: angiomatous lesions with pathological features of PG (PG-like) and congenital onset on the skin and other organs (Disseminated). Responsiveness to β-blockers is previously unknown and cannot be firmly established based on our findings.
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